Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
OPTR (NASDAQ: OPTR)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 03, 2009 04:15 PM |
OPTR
Optimer Pharmaceuticals to Present at November 2009 Investor Conferences
Oct 26, 2009 08:03 AM |
OPTR
Optimer Pharmaceuticals Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting
Oct 19, 2009 08:00 AM |
OPTR
Optimer Pharmaceuticals to Present at October 2009 Investor Conferences
Sep 28, 2009 08:01 AM |
OPTR
Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
Sep 15, 2009 01:45 PM |
CDI
,
OPTR
Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Sep 14, 2009 02:15 PM |
OPTR
Optimer Pharmaceuticals to Present at September 2009 Investor Conferences
Sep 03, 2009 08:01 AM |
OPTR
,
UBS
Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
Sep 02, 2009 08:01 AM |
CDI
,
OPTR
11 Hot Stocks To Short & Mark Cuban Getting Caught For Insider Trading On Copernic Inc. (CNIC)
Nov 17, 2008 01:29 PM |
DFT
,
FUQI
,
GENT
Starting To Get Worried But Not Really
Aug 22, 2008 10:22 AM |
FNM
,
FRE
,
MPWR
,
OPTR
More..
Optimer Posts Loss
Mar 11, 2009 02:52 PM |
OPTR
Optimer to Secure $32.9 Million in Registered Direct Offering
Mar 06, 2009 10:55 AM |
OPTR
More..
Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 05, 2009 08:01 AM |
OPTR
Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
Aug 04, 2009 08:01 AM |
OPTR
Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
Jun 04, 2009 08:02 AM |
OPTR
Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
Jun 02, 2009 03:35 PM |
OPTR
Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
May 17, 2009 03:30 AM |
OPTR
Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
May 07, 2009 08:02 AM |
CEPH
,
OPTR
Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
Apr 13, 2009 09:54 AM |
OPTR
Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results
Mar 11, 2009 02:37 PM |
OPTR
Optimer Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
Mar 09, 2009 08:04 AM |
OPTR
Optimer Pharmaceuticals to Raise $32.9 Million in Registered Direct Offering
Mar 05, 2009 08:06 AM |
OPTR
More..
Form 4 Che Tessie M For: May 15 (10K)
May 18, 2009 06:24 PM
Form 4 Chang Michael N For: May 15 (10K)
May 18, 2009 06:03 PM
Form 4 Prunty John D For: May 15 (10K)
May 18, 2009 02:33 PM
Form 4 Gorbach MD Sherwood For: Apr 06 (10K)
Apr 08, 2009 01:07 PM
Form 4 SCHREIBER ALAIN For: Mar 04 (10K)
Mar 06, 2009 08:51 PM
Form 3 OPTIMER PHARMACEUTICALS For: Feb 19 Filed by: Frapaise Francois-Xavier (10K)
Feb 24, 2009 11:15 AM
Form 3 OPTIMER PHARMACEUTICALS For: Feb 19 Filed by: GREBOW PETER E (10K)
Feb 24, 2009 11:11 AM
Form 4 OPTIMER PHARMACEUTICALS For: Feb 19 Filed by: Frapaise Francois-Xavier (10K)
Feb 23, 2009 09:04 PM
Form 4 OPTIMER PHARMACEUTICALS For: Feb 19 Filed by: GREBOW PETER E (10K)
Feb 23, 2009 08:42 PM
Form 4 OPTIMER PHARMACEUTICALS For: Jan 08 Filed by: SCHREIBER ALAIN (10K)
Jan 12, 2009 12:46 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
OPTR
Compare to S&P
YTD
-4.54 %
-16.79 %
4 Weeks
-13.34 %
-14.26 %
12 Weeks
-13.80 %
-15.94 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-2.78 %
EPS Growth in Last Year:
-27.59 %
Sales Growth in Last Quarter:
412.05 %
Sales Growth in Last Quarter:
151.48 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
